Zobrazeno 1 - 10
of 22
pro vyhledávání: ''
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
Background. Retinal vein occlusion (RVO) is the second most common vision-threatening retinal vascular disease. Intravitreal dexamethasone implant has been applied to treat macular edema secondary to RVO (RVO-ME). However, the alteration of morpholog
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
Acute pancreatitis (AP) is a common acute abdominal disease with a mortality rate of about 30%. Acute lung injury (ALI) is a common systemic complication of acute pancreatitis, with progressive hypoxemia and respiratory distress as the main manifesta
Autor:
Gulinigaer Tuerhongjiang, Xiaofang Bai, Manyun Guo, Zuyi Yuan, Jianqing She, Xiangrui Qiao, Ruifeng Li, Lizhe Sun, Yue Wu, Bowen Lou, Juan Zhou, Chenbo Xu, Yiming Hua
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
Background. Emerging evidence demonstrates that the lipid metabolism in acute coronary syndrome (ACS) patients with type 2 diabetes mellitus (T2DM) differs from nondiabetic patients. However, the distinct lipid profiles and their relationships with t
Autor:
Shujie Wang, Xijun He, Fandan Meng, Jianan Wu, Yan-Dong Tang, Hongliang Cui, Xuehui Cai, Gang Wang, Menghang Wang, Yu Wang, Yabin Tu, Ying Yu
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
The clinical outcome of porcine circovirus 3 (PCV3) infection is still controversial. Herein, a novel PCV3 isolate (PCV3-China/DB-1/2017) with the molecular characterization of 24A and 27K in the Cap protein was used to inoculate three-week-old cesar
Publikováno v:
Disease Markers, Vol 2021 (2021)
Disease Markers
Disease Markers
Background. There is evidence that the immune system plays a key critical role in the pathogenesis of myocardial infarction (MI). However, the exact mechanisms associated with immunity have not been systematically uncovered. Methods. This study used
Autor:
Qidang Huang, Yuqi Liu, Xin Guo, Tianwang Li, Weiming Deng, Z. Zhong, Yukai Huang, Junming Chen
Publikováno v:
Disease Markers, Vol 2021 (2021)
Disease Markers
Disease Markers
Objective. This study is aimed at investigating the diagnostic value of synovial fluid cell counts in gout patients. Methods. A total of 185 gout, 64 rheumatoid arthritis (RA), 26 axial spondyloarthritis (axSpA), and 24 osteoarthritis (OA) patients w
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Objective. Neural crest stem cells (NCSCs) are prototypically migratory cells immigrating from the dorsal neural tube to specific embryonic sites where they generate a variety of cell types. A lot of biomarkers for NCSCs have been identified. However
Autor:
Przemysław Sikora, Beata Bieniaś
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Renal tubulointerstitial fibrosis caused by congenital ureteropelvic junction obstruction (UPJO) may lead to the development of obstructive nephropathy (ON) and the impairment of kidney function. Hence, the identification of early biomarkers of this
Autor:
Camelia Larisa Vonica, Cerasela Mihaela Goidescu, Roxana Mihaela Chiorescu, Florin Petru Anton, Luminița Animarie Vida-Simiti, Mihaela Mocan, Anca Daniela Farcas, Mocan-Hognogi Larisa Diana, Mirela Anca Stoia
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Background. sST2 represents a useful biomarker for the diagnosis and prognosis of patients with heart failure, but limited data is available on its role in patients with hypertension. The aim of this study is to evaluate the short-term prognosis valu
Autor:
Małgorzata Sobieszczańska-Małek, Marcin Kruszewski, Kamil Brzóska, Barbara Sochanowicz, Witold Śmigielski, Mariusz Kuśmierczyk, Przemysław Leszek, Piotr Rozentryt, Leszek Kraj, Tomasz Rywik
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Background. Heart failure patients presenting with iron deficiency can benefit from systemic iron supplementation; however, there is the potential for iron overload to occur, which can seriously damage the heart. Therefore, myocardial iron (M-Iron) c